Shibata, T., Shibata, S., Ishigaki, Y., Kiyokawa, E., Ikawa, M., Singh, D. P., . . . Kubo, E. (2018). Tropomyosin 2 heterozygous knockout in mice using CRISPR-Cas9 system displays the inhibition of injury-induced epithelial-mesenchymal transition, and lens opacity. Mech Ageing Dev.
Chicago Style citaatShibata, Teppei, Shinsuke Shibata, Yasuhito Ishigaki, Etsuko Kiyokawa, Masahito Ikawa, Dhirendra P. Singh, Hiroshi Sasaki, en Eri Kubo. "Tropomyosin 2 Heterozygous Knockout in Mice Using CRISPR-Cas9 System Displays the Inhibition of Injury-induced Epithelial-mesenchymal Transition, and Lens Opacity." Mech Ageing Dev 2018.
MLA citatieShibata, Teppei, et al. "Tropomyosin 2 Heterozygous Knockout in Mice Using CRISPR-Cas9 System Displays the Inhibition of Injury-induced Epithelial-mesenchymal Transition, and Lens Opacity." Mech Ageing Dev 2018.